Time to recurrence and survival in serous ovarian tumors predicted from integrated genomic profiles.

Serous ovarian cancer (SeOvCa) is an aggressive disease with differential and often inadequate therapeutic outcome after standard treatment. The Cancer Genome Atlas (TCGA) has provided rich molecular and genetic profiles from hundreds of primary surgical samples. These profiles confirm mutations of...

Full description

Bibliographic Details
Main Authors: Parminder K Mankoo, Ronglai Shen, Nikolaus Schultz, Douglas A Levine, Chris Sander
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3207809?pdf=render

Similar Items